Targeted, disease-modifying therapy for neuro-excitatory disorder patients who have run out of options
Stop Seizures - R2B Project is dedicated to advancing public health through innovative therapeutic solutions. Located in Helsinki, 00290, FI, Stop Seizures - R2B Project focuses on developing a targeted, disease-modifying therapy for neuro-excitatory disorder patients who have exhausted other options.
With a commitment to improving the lives of individuals affected by epilepsy, Stop Seizures - R2B Project addresses the critical need for more effective and tolerable treatments. The project's therapeutic approach offers a promising alternative by specifically targeting diseased neurons, minimizing the side effects often associated with traditional therapies. Funded by Business Finland and the University of Helsinki, Stop Seizures - R2B Project is driven by a team of scientific experts and commercialization specialists.
Stop Seizures - R2B Project is committed to making a significant impact in the field of neurology. We invite the manager of Stop Seizures - R2B Project to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.
Other organizations in the same industry
This company is also known as